Clinical Trials Logo

Filter by:
NCT ID: NCT03428841 Completed - Hearing Loss Clinical Trials

Audiovisual Assessment After Dural Puncture During Epidural Placement in Obstetric Patients

Start date: September 25, 2007
Phase: N/A
Study type: Observational

The study involves assessment of hearing and visual complications along with headache after accidental dural puncture in patients receiving epidurals. Hearing loss will be assessed by clinical examination and audiometry testing, while visual complications will be assessed by clinical examination. The patients will receive standard treatment for headache in the form of drugs and if required an epidural blood patch ( injecting patient's blood in the epidural space). The course of these complications and response to treatment will be investigated over a period of time. Audiometry results from patients with dural puncture will be compared to those of patients who also had epidurals, but without a dural puncture. The investigators hypothesize that audiovisual complications occur more frequently in patients having accidental dural puncture with epidural needle and that the symptoms resolve with the administration of epidural blood patch.

NCT ID: NCT03427671 Completed - Leiomyoma Clinical Trials

OCL 500 Treatment of Women With Symptomatic Uterine Fibroids

Start date: January 17, 2018
Phase: N/A
Study type: Interventional

This is a prospective, open-label, single-arm, safety and effectiveness study of Occlusin 500 microspheres in women with symptomatic uterine fibroids.

NCT ID: NCT03427385 Completed - Clinical trials for Neuromuscular Blockade

Minimum Local Anesthetic Dose for Adductor Canal Block

Start date: September 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the minimum dose of ropivacaine 0.5%, required to produce pain relief without weakening the leg muscles.

NCT ID: NCT03427268 Completed - Clinical trials for Advanced Colorectal Cancer

Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard Treatment

Start date: January 16, 2018
Phase: Phase 2
Study type: Interventional

This trial will evaluate the efficacy of PM060184 in terms of progression-free survival at 12 weeks (PFS3) in advanced or metastatic Colorectal Cancer (CRC) patients with any KRAS mutation status (wild- type; mutated; or unknown status) progressing after standard treatments (fluoropyrimidine, irinotecan, and oxaliplatin). Patients in this trial will receive PM060184 at a dose of 9.3 mg/m2 as a 30-minute intravenous (i.v.) infusion on Days 1 and 8 q3wk.

NCT ID: NCT03426072 Completed - Nursing Homes Clinical Trials

Safer Care for Older People in (Residential) Environments

SCOPE
Start date: January 4, 2018
Phase: N/A
Study type: Interventional

The overall aim of the program is to advance knowledge translation science in order to improve clinical and staff related outcomes in long term care facilities (nursing homes) in western Canada. SCOPE will assess the effect of Care Aide led Quality Improvement efforts on staff quality of work life as well as resident quality of care. A key element of SCOPE is a leadership development stream which introduces complexity science and education on quality improvement which aims to support front line teams with their improvement initiative

NCT ID: NCT03426033 Completed - Clinical trials for Cardiovascular Diseases

Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Warfarin

Start date: December 15, 2017
Phase: Phase 1
Study type: Interventional

This is a single center, open label, single sequence, two-treatment, two-period drug-drug interaction study to evaluate the effect of multiple doses of ISIS 681257 on the pharmacokinetics of a single dose of warfarin.

NCT ID: NCT03425617 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Effects of Dual Bronchodilator Treatment on Cardiopulmonary Interactions in COPD

Start date: January 1, 2017
Phase: Phase 4
Study type: Interventional

The deleterious consequences of lung hyperinflation seem not to be restricted to the respiratory system in patients with chronic obstructive pulmonary disease (COPD). Cardiac function, in particular, is strongly influenced by changes in lung volumes and intra-thoracic pressures. In this context, strategies to reduce lung hyperinflation and the work of breathing can positively impact upon cardiac output and blood flow redistribution to peripheral muscles in these patients. There is growing evidence that combination of bronchodilators of different classes is an efficacious and safe strategy for further improving airflow obstruction and hyperinflation in patients with more advanced COPD. Therefore, we aim to investigate that, compared with placebo, a novel LABA/LAMA fixed combination (tiotropium 5 mcg plus olodaterol 5 mcg via Respimat® (Inspiolto®) (TIO/OLO) would decrease lung volumes at rest and during exercise, thereby improving: 1) central and peripheral hemodynamics and 2) arterial oxygenation, with positive consequences on skeletal muscle oxygenation and exercise tolerance in hyperinflated patients with moderate to very severe COPD.

NCT ID: NCT03425578 Completed - Healthy Clinical Trials

Glutamate Supplementation in Young Men

Start date: March 19, 2018
Phase: N/A
Study type: Interventional

Amino acids play an important role in human metabolism. In aging individuals and in some diseases, certain amino acids, such as glutamate, are at lower than normal levels. Glutamate appears to be involved in providing energy and maintaining normal blood sugar (glucose) levels, processes which both depend heavily on skeletal muscle. The maintenance of healthy blood sugar levels, in particular, is tightly related to overall muscle mass and quality. To better understand the link between glutamate and glucose metabolism in skeletal muscle, the investigators will be using a nutritional approach to raise the body's glutamate levels with monosodium glutamate (MSG) supplementation, and raise blood glucose levels with a sugary drink. By altering the normal levels of glutamate and glucose in the blood and muscle tissue, the investigators can gather more information about the role of glutamate in energy metabolism. This will help the design of future studies investigating the function of glutamate in aging and disease. During this study the investigators will increase the levels of glutamate and glucose in the bloodstream by asking participants to ingest MSG along with a sugary drink. The goal is to subsequently determine: A) the amount of glutamate and glucose that ends up in the muscle; and B) whether normal skeletal muscle glucose metabolism, and the behaviour of additional amino acids (other than glutamate) is altered. The hypothesis is that when MSG and sugar drink are ingested together glucose uptake and metabolism within the skeletal muscle will be elevated.

NCT ID: NCT03425539 Completed - Fabry Disease Clinical Trials

Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease

MODIFY
Start date: June 21, 2018
Phase: Phase 3
Study type: Interventional

This study aimed to determine the efficacy and safety of lucerastat oral monotherapy in adult subjects with Fabry disease.

NCT ID: NCT03424694 Completed - Prostate Cancer Clinical Trials

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer

BRP2
Start date: June 22, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate High-dose rate (HDR) brachytherapy (1 vs 2 fractions on single implant) as monotherapy for the treatment of low risk and intermediate risk prostate cancer